|
Compound | Chemical class | Test model | Possible mechanism | Reference |
|
(1) (3β, 16α, 20α)-3, 16, 28-Trihydroxyolean-12-en-29-oic acid 3-{O-β-D-glucopyranosyl (1 ⟶ 2)-O-[β-D-glucopyranosyl (1 ⟶ 4)]-α-L-arabinopyranoside} | Triterpenoid saponin | In vitro anti-inflammatory test using female C57BL/6 mice bone marrow | Inhibitors of cytokines TNF-α, IL-6, and IL-12 p40 | [14] |
(2) Aegicoroside A |
|
(1) 3-O-[α-L-Rhamnopyranosyl-(1 ⟶ 2)-α-L-rhamnopyranosyl-(1 ⟶ 2)-β-D-galactopyranosyl-(1 ⟶ 3)-β-D-glucopyranosyl-(1 ⟶ 2)-β-D-(6′-O-methyl)glucuronopyranosyl]-13β, 28-epoxy-3β, 16α-dihydroxy-olean | Triterpenoid saponin | In vitro apoptosis test using B16F10 melanoma cells | N/A | |
(2) Sakurasosaponin |
|
(1) 2,5-Didehydroxy-6-methylembelin | Benzoquinone | In vitro antimalarial activity using chloroquine-sensitive (3D7) and resistant (K1) strains | N/A | [24] |
(2) Embelin |
(3) 5-O-Ethylembelin |
(4) 5-O-Methylembelin |
(5) Acetylation of 5-O-methylembelin |
|
(1) Acornine 1 | Triterpenoid saponin | In vitro antifungal effect using S. cerevisiae and T. clypeatus and antimicrobial effect using Bacillus subtilis and Bacillus coagulans | N/A | [7] |
(2) Acornine 2 |
|
(1) 2-Hydroxy-5-ethoxy-3-nonyl1,4-benzoquinone | Benzoquinones | In vitro cytotoxic activities against HL-60, HepG2, BGC-823, NCI-H1650, and A2780 cell lines by the MTT assay | N/A | [23] |
(2) 5-O-Butyl-embelin |
(3) 5-O-Methylembelin |
(4) 5-O-Methyl-rapanone |
(5) 5-O-Ethylembelin |
|
(1) Gallic acid | Polyphenolic acid | In vitro allelopathic effects on Cyclotella caspia | Through oxidation it damages cell membrane and cellular components | [11] |
|
(1) 5-O-Ethylembelin | Benzoquinone | In vitro cytotoxicity test against the HL-60, Bel7402, Hela, and U937 cell lines | N/A | [16] |
(2) 5-O-Methylembelin |
|
(1) Sakurasosaponin | Triterpenoid saponin | In vitro cytotoxic activities of the isolated compounds against MCF7 (breast), HCT116 (colon), B16F10 (melanoma), and A549 (adenocarcinoma) cancer cell lines | N/A | [19] |
(2) Sakurasosaponin methyl ester |
|
(1) Gallocatechin | Tannin | DPPH radical scavenging | By scavenging free radicals | [25] |
(2) Epigallocatechin | Ferric reducing antioxidant assay | By reduction of TPTZ-Fe (III) to TPTZ-Fe (II) |
(3) Epigallocatechin-3-O-gallate |
(4) Epicatechin-3-O-gallate |
(5) Epicatechin |
|
(1) Methyl cis-5, 8, 11, 14- eicosatrienoic acid | Fatty acid | Antimicrobial assay of fatty acids through using disk diffusion method using S. aureus, E. coli, K. pneumonia, and P. aeruginosa | Due to the metabolic oxidation products of fatty acids | [20] |
(2) Linoleic acid |
(3) Palmitic acid |
(4) Lignoceric acid |
(5) cis-10-Heptadecanoic acid |
(6) Stearic acid |
(7) Oleic acid |
(8) Palmitoleic acid |
|
(1) Quercetin | Flavonoid | In vitro anti-inflammatory activity through cytokine inhibition | Suppressed the activity of both cyclooxygenase (COX) and 5-lipoxygenase (5-LOX), resulting in a significant reduction in the synthesis of 12-hydroxyheptadecatrienoic acid (12-HHT) and leukotriene B4 (LTB4) | [43] |
(2) Kaempferol |
(3) Isorhamnetin |
|
(1) Sakurasosaponin | Saponin | In vivo S-saponin induced AR deficiency to check suppression of tumor growth | Decreased mitochondrial membrane potential, increased cytochrome c release into the cytoplasm, elevated caspase-3 activity, and induced apoptosis | [50] |
|
(1) 2-O-(2-Methylpropyl) 1-O-pentyl oxalate | Oxalate | In silico antidiabetes test | DPP-IV inhibition | [21] |
|